Lebrikizumab
82692
Product group Antibodies
Overview
- SupplierBPS Bioscience
- Product NameLebrikizumab
- Delivery Days Customer23
- CertificationResearch Use Only
- ClonalityMonoclonal
- Estimated Purity≥90%
- HostHamster
- IsotypeIgG4
- Scientific DescriptionLebrikizumab (TNX-650) is an IgG4 humanized anti-interleukin-13 (IL-13) mAb with anti-itch effects that specifically binds to IL-13 in a non-receptor binding domain and inhibits its function. Lebrikizumab inhibits the IL-13 driven Th2 inflammatory response and blocks the signaling of IL-4Ralpha/IL-13Ralpha1. Lebrikizumab can be used for the research of asthma, atopic dermatitis and neuroinflammatory diseases1,2,3.
- Storage Instruction-80°C
- UNSPSC12352203